XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.1
Acquisitions, Research Collaborations and License Agreements (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended
Jan. 31, 2021
Mar. 31, 2021
Artiva Biotherapeutics, Inc. | Licensing Agreements    
Business Acquisition [Line Items]    
Upfront and milestone payments $ 30.0  
Upfront and milestone payments to be made $ 15.0  
Artiva Biotherapeutics, Inc. | Licensing Agreements | Minimum    
Business Acquisition [Line Items]    
Royalty rate 7.00%  
Artiva Biotherapeutics, Inc. | Licensing Agreements | Maximum    
Business Acquisition [Line Items]    
Royalty rate 14.00%  
Artiva Biotherapeutics, Inc. | Licensing Agreements | Development Milestones    
Business Acquisition [Line Items]    
Contingent milestone payments collaborative arrangement $ 217.5  
Artiva Biotherapeutics, Inc. | Licensing Agreements | Regulatory Milestones    
Business Acquisition [Line Items]    
Contingent milestone payments collaborative arrangement 570.0  
Artiva Biotherapeutics, Inc. | Licensing Agreements | Sales-Based Milestones    
Business Acquisition [Line Items]    
Contingent milestone payments collaborative arrangement $ 1,050.0  
COVID-19    
Business Acquisition [Line Items]    
Charges related to program discontinuation   $ 170.0